Published in BMC Immunol on February 16, 2009
Endoplasmic reticulum stress and atherosclerosis. Nat Med (2010) 1.78
ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity. PLoS One (2009) 1.13
Emerging functions of the unfolded protein response in immunity. Nat Immunol (2014) 1.10
Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol (2013) 1.10
The current Salmonella-host interactome. Proteomics Clin Appl (2011) 1.08
The Salmonella type III secretion effector, salmonella leucine-rich repeat protein (SlrP), targets the human chaperone ERdj3. J Biol Chem (2010) 1.04
The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol (2011) 0.96
Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming. PLoS One (2012) 0.96
Role of fatty-acid synthesis in dendritic cell generation and function. J Immunol (2013) 0.92
The UPR and lung disease. Semin Immunopathol (2013) 0.86
The unfolded protein response in immunity and inflammation. Nat Rev Immunol (2016) 0.86
Comparing human-Salmonella with plant-Salmonella protein-protein interaction predictions. Front Microbiol (2015) 0.86
The unfolded protein response in lung disease. Proc Am Thorac Soc (2010) 0.85
The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells. Oncogene (2015) 0.83
Micro(RNA)managing endoplasmic reticulum stress. IUBMB Life (2013) 0.83
Perception of self: distinguishing autoimmunity from autoinflammation. Nat Rev Rheumatol (2015) 0.81
A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis. Mol Cell Proteomics (2013) 0.81
ER Stress and Iron Homeostasis: A New Frontier for the UPR. Biochem Res Int (2010) 0.80
Bordetella adenylate cyclase toxin differentially modulates toll-like receptor-stimulated activation, migration and T cell stimulatory capacity of dendritic cells. PLoS One (2014) 0.80
Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancers. Sci Rep (2016) 0.76
Immunomorphologic manifestations in mice liver infected with influenza A/H5N1, A/goose/Krasnoozerskoye/627/05 strain. Clin Dev Immunol (2013) 0.76
Endoplasmic Reticulum Proteostasis: A Key Checkpoint in Cancer. Am J Physiol Cell Physiol (2016) 0.75
Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment. Front Endocrinol (Lausanne) (2017) 0.75
Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol (2007) 33.06
Upstream and downstream of mTOR. Genes Dev (2004) 21.61
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell (2001) 18.68
The mammalian unfolded protein response. Annu Rev Biochem (2005) 16.31
XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol (2003) 11.17
Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell (2000) 11.09
Translational control in stress and apoptosis. Nat Rev Mol Cell Biol (2005) 8.91
Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep (2006) 8.16
Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol (2003) 6.95
Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science (2006) 6.75
Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol (2006) 6.45
Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol (2006) 6.13
Endoplasmic reticulum stress signaling in disease. Physiol Rev (2006) 5.90
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity (1997) 5.44
A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell (2003) 4.99
mTOR, translation initiation and cancer. Oncogene (2006) 4.68
Peptides naturally presented by MHC class I molecules. Annu Rev Immunol (1993) 4.66
Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol (1998) 4.54
T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat Immunol (2008) 4.52
Dietary fat intake does affect obesity! Am J Clin Nutr (1998) 4.26
Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell (2008) 3.91
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J (2005) 3.79
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell (2007) 3.76
Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res (2006) 3.64
The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods (2005) 3.40
Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway. Cell (2006) 3.26
Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science (1993) 3.06
Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem (2002) 3.02
Diverse and specific gene expression responses to stresses in cultured human cells. Mol Biol Cell (2004) 3.02
Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol (2003) 3.00
Obesity and infection. Lancet Infect Dis (2006) 2.94
Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J Cell Biol (2006) 2.76
Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem (1995) 2.76
CD8 T cell responses to infectious pathogens. Annu Rev Immunol (2001) 2.68
Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload. Cell (2006) 2.54
Integrated endoplasmic reticulum stress responses in cancer. Cancer Res (2007) 2.43
The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol (2006) 2.42
Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J Virol (2002) 2.39
Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc Natl Acad Sci U S A (1997) 2.08
Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes. Am J Physiol Endocrinol Metab (2007) 1.90
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol (2005) 1.85
The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J Immunol (1999) 1.72
Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. Proc Natl Acad Sci U S A (1998) 1.72
Plumbing the sources of endogenous MHC class I peptide ligands. Curr Opin Immunol (2006) 1.47
Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol (2000) 1.40
Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med (2007) 1.40
Carboxypeptidase E mediates palmitate-induced beta-cell ER stress and apoptosis. Proc Natl Acad Sci U S A (2008) 1.39
Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity (2003) 1.36
Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc Natl Acad Sci U S A (1997) 1.34
The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med (2008) 1.31
Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol (2004) 1.29
All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol Rev (2005) 1.27
Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol (2006) 1.27
Stable ribosome binding to the endoplasmic reticulum enables compartment-specific regulation of mRNA translation. Mol Biol Cell (2005) 1.21
Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother Emphasis Tumor Immunol (1993) 1.20
Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo. J Immunol (2000) 1.09
T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med (2005) 1.06
Rethinking peptide supply to MHC class I molecules. Nat Rev Immunol (2007) 1.05
Stimulation of an unfolded protein response impairs MHC class I expression. J Immunol (2007) 0.99
HFE cross-talks with the MHC class I antigen presentation pathway. Blood (2005) 0.96
A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. J Immunol Methods (1987) 0.96
The immune response under stress: the role of HSP-derived peptides. Trends Immunol (2004) 0.91
Differential regulation of the ER stress response by long-chain fatty acids in the pancreatic beta-cell. Biochem Soc Trans (2008) 0.91
Targeting plasmid-encoded proteins to the antigen presentation pathways. Immunol Rev (2004) 0.90
Why T cells of thymic versus extrathymic origin are functionally different. J Immunol (2008) 0.89
Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease. J Clin Invest (1996) 0.88
Differential effects of a saturated and a monounsaturated fatty acid on MHC class I antigen presentation. Scand J Immunol (2008) 0.86
Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells. J Invest Dermatol (2000) 0.85
ER stress induces alternative nonproteasomal degradation of ER proteins but not of cytosolic ones. Cell Stress Chaperones (2007) 0.84
The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. Int Immunol (2005) 0.84
Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum. J Immunol (2002) 0.84
FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development (2007) 5.62
An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep (2003) 2.52
An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme. Cell (2011) 2.35
Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc Natl Acad Sci U S A (2007) 1.93
From basic research to clinical development of MEK1/2 inhibitors for cancer therapy. J Hematol Oncol (2010) 1.92
MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood (2012) 1.79
IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization. J Immunol (2005) 1.72
The IKK-related kinases: from innate immunity to oncogenesis. Cell Res (2008) 1.71
MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation (2004) 1.69
Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum (2006) 1.69
A comprehensive map of the mTOR signaling network. Mol Syst Biol (2010) 1.59
Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ Res (2010) 1.56
Atypical mitogen-activated protein kinases: structure, regulation and functions. Biochim Biophys Acta (2006) 1.56
Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APC(Cdh1) in G1 phase. EMBO J (2008) 1.53
Interpreting neonatal lethal phenotypes in mouse mutants: insights into gene function and human diseases. Physiol Rev (2009) 1.53
Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease. Blood (2010) 1.49
Differential effects of γc cytokines on postselection differentiation of CD8 thymocytes. Blood (2012) 1.46
Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. EMBO J (2004) 1.43
Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev (2010) 1.42
N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol (2004) 1.40
Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med (2007) 1.40
ERKs in cancer: friends or foes? Cancer Res (2014) 1.37
Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation. Mol Cell Biol (2003) 1.35
A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics (2010) 1.34
The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med (2008) 1.31
A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med (2009) 1.31
Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J Biol Chem (2004) 1.24
The eIF4E RNA regulon promotes the Akt signaling pathway. J Cell Biol (2008) 1.22
Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol Cell Biol (2003) 1.22
Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5. J Cell Physiol (2008) 1.20
Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J Virol (2008) 1.19
Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression. J Biol Chem (2003) 1.19
Involvement of the IkappaB kinase (IKK)-related kinases tank-binding kinase 1/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation. J Immunol (2006) 1.19
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes Dev (2013) 1.18
Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4. J Biol Chem (2006) 1.16
Nras(G12D/+) promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions. Blood (2013) 1.15
Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2. Cell Cycle (2010) 1.13
Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality. Proc Natl Acad Sci U S A (2009) 1.12
Memory T-lymphocyte survival does not require T-cell receptor expression. Proc Natl Acad Sci U S A (2008) 1.12
Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol (2007) 1.09
Cyclic AMP induces morphological changes of vascular smooth muscle cells by inhibiting a Rac-dependent signaling pathway. J Cell Physiol (2005) 1.09
Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation. Mol Cell Biol (2010) 1.07
Circadian variation of the response of T cells to antigen. J Immunol (2011) 1.07
T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med (2005) 1.06
The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-catenin-independent signaling. Immunity (2008) 1.04
E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells. Genes Dev (2006) 1.04
Clinical and genetic study of autosomal recessive cerebellar ataxia type 1. Ann Neurol (2007) 1.03
P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. Blood (2002) 1.03
p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J Cell Biol (2005) 1.03
The stress model of chronic pain: evidence from basal cortisol and hippocampal structure and function in humans. Brain (2013) 1.02
Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors. BMC Cancer (2008) 1.01
Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway. J Biol Chem (2010) 1.01
Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions. Mol Syst Biol (2013) 0.99
Origin and plasticity of MHC I-associated self peptides. Autoimmun Rev (2011) 0.99
Wnt4 enhances murine hematopoietic progenitor cell expansion through a planar cell polarity-like pathway. PLoS One (2011) 0.98
T regulatory cells control numbers of NK cells and CD8alpha+ immature dendritic cells in the lymph node paracortex. J Immunol (2007) 0.97
A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations. Blood (2010) 0.97
The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol (2011) 0.96
The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology. Mol Cell Biol (2012) 0.96
C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis. Biochem J (2010) 0.96
Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1. J Biol Chem (2002) 0.96
Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells. Exp Hematol (2007) 0.95
EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors. Am J Physiol Cell Physiol (2002) 0.95
Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity. PLoS Pathog (2012) 0.95
T-cell generation by lymph node resident progenitor cells. Blood (2005) 0.95
Acute stress contributes to individual differences in pain and pain-related brain activity in healthy and chronic pain patients. J Neurosci (2013) 0.93
EN2 is a candidate oncogene in human breast cancer. Oncogene (2005) 0.93
Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation. Arterioscler Thromb Vasc Biol (2003) 0.93
Transcriptome sequencing of neonatal thymic epithelial cells. Sci Rep (2013) 0.92
Liver fibrosis protects mice from acute hepatocellular injury. Gastroenterology (2011) 0.92
Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy. Blood (2002) 0.92
Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol Cell Proteomics (2010) 0.92
Development and functional properties of thymic and extrathymic T lymphocytes. Crit Rev Immunol (2008) 0.90
Next-generation leukemia immunotherapy. Blood (2011) 0.90
Artifactual sulfation of silver-stained proteins: implications for the assignment of phosphorylation and sulfation sites. Mol Cell Proteomics (2008) 0.89
ProteoConnections: a bioinformatics platform to facilitate proteome and phosphoproteome analyses. Proteomics (2011) 0.89
CD8 T-cell ability to exert immunodomination correlates with T-cell receptor: epitope association rate. Biol Blood Marrow Transplant (2005) 0.89
Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation. Cancer Res (2012) 0.89
Why T cells of thymic versus extrathymic origin are functionally different. J Immunol (2008) 0.89
Development and function of innate polyclonal TCRalphabeta+ CD8+ thymocytes. J Immunol (2011) 0.88
The model B6(dom1) minor histocompatibility antigen is encoded by a mouse homolog of the yeast STT3 gene. Immunogenetics (2002) 0.88
The protein kinase ERK3 is encoded by a single functional gene: genomic analysis of the ERK3 gene family. Genomics (2002) 0.88
Wnt4 regulates thymic cellularity through the expansion of thymic epithelial cells and early thymic progenitors. Blood (2011) 0.88
Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts. Blood (2008) 0.88
Targeted inactivation of Mapk4 in mice reveals specific nonredundant functions of Erk3/Erk4 subfamily mitogen-activated protein kinases. Mol Cell Biol (2010) 0.87
Dual-tag prokaryotic vectors for enhanced expression of full-length recombinant proteins. Anal Biochem (2002) 0.87
Thymic and extrathymic T cell development pathways follow different rules. J Immunol (2002) 0.86
The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. Circ Res (2011) 0.86
Adult thymic epithelium contains nonsenescent label-retaining cells. J Immunol (2014) 0.85